Company intelligence / Profile preview

广东方盛融大药业

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangdong Fangsheng Rongda Pharmaceutical is a specialized pharmaceutical subsidiary of the publicly traded Hunan Fangsheng Pharmaceutical group. The company focuses on the research, development, and large-scale manufacturing of Traditional Chinese Medicines (TCM) and chemical drug formulations. Its core product portfolio is centered on therapeutic areas such as orthopedics, cardiovascular health, and pediatrics, featuring several well-established TCM brands in the Chinese market. Fangsheng Rongda operates modern, GMP-compliant production facilities and serves as a key regional hub for the parent company's operations in Southern China.

Therapeutic areas: RheumatologyOtherInfectious DiseasesCardiovascular
Modalities: Herbal medicineSmall moleculeBotanical extract
Industry: Pharma

Beyond the preview

Go deeper on 广东方盛融大药业.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 广东方盛融大药业.

Explore the full profile